SNDX Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications.

$16.14  +0.03 (0.19%)
As of 12/03/2021 15:59:58 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/03/2016
Outstanding shares:  49,392,123
Average volume:  449,673
Market cap:   $795,707,102
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    87164F105
ISIN:        US87164F1057
Sedol:      BN7Q7R7
Valuation   (See tab for details)
PE ratio:   -8.67
PB ratio:   3.95
PS ratio:   58.89
Return on equity:   -46.08%
Net income %:   -678.62%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy